Better Cannabis Stock: Hexo (TSX:HEXO) vs. Charlotte’s Web Holdings (CNSX:CWEB)

Hexo Corp (TSX:HEXO) has made strides recently, but could this U.S.-based CBD company be a better buy?

| More on:
edit Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Choosing between the hundreds of companies looking to profit from the growing cannabis sector isn’t easy. While some might win big in the long run, many others will likely end up on the sidelines at best. Let’s turn our attention to two potential big players in the cannabis sector: Hexo (TSX:HEXO) and Charlotte’s Web Holdings (CNSX:CWEB). Which of these is the better buy?

The case for Hexo

Hexo is increasingly becoming an attractive pot stock. While the firm currently focuses on the recreational marijuana market — an overpopulated and low-margin opportunity — Hexo currently holds about 30% of the market share in the province of Quebec, thanks to a supply agreement it signed last year.

Recently, Hexo acquired Newstrike Brands, a Toronto-based cannabis company whose 1.8 million square feet of cultivation space should come in handy. This move should allow Hexo’s production capacity (at peak) to hover around 150,000 kilograms per year, which is very competitive by industry’s standard.

Further, Hexo entered into a partnership with Molson Coors Brewing last year. This venture should give birth to cannabis-infused beverages, which are set to become legal later this year. Thus, Hexo is looking for higher-margin opportunities, which will be critical if it wants to establish itself as one of the leaders in the industry.

Hexo is expecting a boost in sales and revenues thanks to its latest acquisition, which should bode well with investors, especially considering the firm’s revenues soared by more than 1,200% over the past year and a half (or so). As a result of several recent developments, Hexo’s valuation metrics look a bit more attractive.

The case for Charlotte’s Web

Charlotte’s Web may not be as popular as some of the biggest players in the pot market, but it would be a mistake to ignore this under-the-radar company. The Colorado-based firm is one of the biggest player in the U.S. hemp CBD market. As you might recall, hemp — a non-psychoactive chemical cousin of marijuana — became legal at the federal level late last year in the U.S when the Farm Bill was signed into law.

Charlotte’s Web has its footprints all over the U.S with 6,000 retail locations across the country. The firm’s production capacity is also increasing at a steady rate. In 2018, Charlotte’s Web planted 300 acres of hemp, a more than 420% increase from 2017. This led to its production increasing to 675,000 pounds (about 306,174 kilograms) in 2018, up from just 63,000 pounds (about 28,576 kilograms) in 2017. The firm plans to plant 600 acres of hemp this year.

Perhaps the most admirable aspect of Charlotte’s Web is the fact that the firm is managing to do something few others in the cannabis sector are doing: generating consistent profits. In 2018, the firm’s revenues were $69,501, up from $40,001 in 2017. Charlotte’s Web cost of sales increased to $17,010 in 2018 from $9,248.

In both years, the company recorded a net income, which totaled $11,808,000 in 2018, up 58% year over year. Charlotte’s Web currently trades at about 20 times future earnings, which is a bargain by comparison to most of its competitors.

Which is the better buy?

Neither company possesses a very strong presence outside North America. However, Charlotte’s Web is currently operating in the largest cannabis market in the world.

While the U.S. has yet to legalize recreational uses of marijuana, the hemp market is not to be ignored, and Charlotte’s Web is consistently increasing its revenues and is even profitable — a rarity in the cannabis sector at the moment.

Though Hexo is also an attractive option — thanks to its major supply agreement with Quebec and its partnership with Molson Coors — it looks to be second place to Charlotte’s Web at this point.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of Molson Coors Brewing. Fool contributor Prosper Bakiny owns shares of Hexo Corp.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »